Ken Fisher Fisher Asset Management
AUM
$276B
1-Year Est. Return
24.78%
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
1 Year Est. Return
+24.78%
AUM
$276B
AUM Growth
+$24.4B
(+9.7%)
Holding
1,094
Top Buys
| 1 | +$2.89B | |
| 2 | +$383M | |
| 3 | +$299M | |
| 4 |
Microsoft
MSFT
|
+$282M |
| 5 |
Apple
AAPL
|
+$226M |
Top Sells
| 1 | +$1.82B | |
| 2 | +$209M | |
| 3 | +$168M | |
| 4 |
Adobe
ADBE
|
+$118M |
| 5 |
Banco Santander
SAN
|
+$104M |
Sector Composition
| 1 | Technology | 26.4% |
| 2 | Financials | 18.68% |
| 3 | Industrials | 9.33% |
| 4 | Healthcare | 8.68% |
| 5 | Communication Services | 6.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Costco
COST
$397B
| $2.91B | 1.05% |
3,145,241
+34,826
|
|
||
27
Bank of America
BAC
$394B
| $2.72B | 0.98% |
52,677,988
+1,272,315
|
|
||
28
Oracle
ORCL
$620B
| $2.54B | 0.92% |
9,045,019
+157,272
|
|
||
29
Visa
V
$639B
| $2.51B | 0.91% |
7,359,223
+98,902
|
|
||
30
UBS Group
UBS
$127B
| $2.51B | 0.91% |
61,168,437
+2,744,348
|
|
||
31
Freeport-McMoran
FCX
$64.9B
| $2.48B | 0.9% |
63,258,414
+899,699
|
|
||
32
Mastercard
MA
$490B
| $2.45B | 0.89% |
4,308,400
+58,478
|
|
||
33
Netflix
NFLX
$425B
| $2.44B | 0.88% |
20,338,750
+144,570
|
|
||
34
BP
BP
$91.5B
| $2.26B | 0.82% |
65,483,232
+1,046,236
|
|
||
35
Blackrock
BLK
$166B
| $2.22B | 0.8% |
1,902,167
-64,136
|
|
||
36
iShares MBS ETF
MBB
$39.1B
| $2.14B | 0.78% |
22,503,900
+1,206,273
|
|
||
37
Charles Schwab
SCHW
$167B
| $2.07B | 0.75% |
21,646,588
+269,898
|
|
||
38
Merck
MRK
$248B
| $2.02B | 0.73% |
24,068,126
-945,571
|
|
||
39
Shell
SHEL
$209B
| $1.92B | 0.69% |
26,809,946
+417,101
|
|
||
40
Johnson Controls International
JCI
$69.8B
| $1.86B | 0.67% |
16,959,249
+354,266
|
|
||
41
Spotify
SPOT
$116B
| $1.82B | 0.66% |
2,602,625
+113,612
|
|
||
42
UnitedHealth
UNH
$300B
| $1.81B | 0.66% |
5,252,449
+38,977
|
|
||
43
Barclays
BCS
$80.6B
| $1.78B | 0.64% |
86,027,312
+2,964,420
|
|
||
44
Intuitive Surgical
ISRG
$204B
| $1.74B | 0.63% |
3,889,439
+40,702
|
|
||
45
Intuit
INTU
$187B
| $1.73B | 0.62% |
2,526,907
-245,547
|
|
||
46
Procter & Gamble
PG
$335B
| $1.69B | 0.61% |
11,008,454
+40,941
|
|
||
47
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
$11B
| $1.63B | 0.59% |
60,589,322
+2,639,099
|
|
||
48
AstraZeneca
AZN
$280B
| $1.62B | 0.59% |
21,162,724
+466,745
|
|
||
49
Abbott
ABT
$217B
| $1.61B | 0.58% |
12,032,884
+170,061
|
|
||
50
Johnson & Johnson
JNJ
$487B
| $1.57B | 0.57% |
8,446,408
+173,936
|
|